9/27/2010 10:53:30 AM
Triangle Business Journal - by James Gallagher -- UNC cancer researchers have won a $13.6 million grant to work to use nanotechnology to improve the diagnosis and treatment of cancer.
The five-year grant from the National Cancer Institute is directed to UNC-Chapel Hill’s Carolina Center of Cancer Nanotechnology Excellence at the UNC Lineberger Comprehensive Cancer Center.
The work will be lead by Joel Tepper and Joseph DeSimone. DeSimone is well known for his work in nanotechnology and has spun of some of his past research into the pharmaceutical startup company Liquidia Technologies, which is collaborating on the project.
“Our efforts in nanomedicine show tremendous promise for improving the ways we detect and treat lung, brain, and breast cancer,” said DeSimone. “We have refined our ability to make nanoparticles with unprecedented control and precision, and continued work in this area will reveal better approaches to targeting cancer cells with potent therapies while leaving healthy cells intact.”
In total, the funding will support 52 faculty, postdoctoral trainees, students and staff members.
comments powered by